These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37189064)

  • 1. ARHGAP39 is a prognostic biomarker involved in immune infiltration in breast cancer.
    Yao L; Li Y; Li S; Wang M; Cao H; Xu L; Xu Y
    BMC Cancer; 2023 May; 23(1):440. PubMed ID: 37189064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma.
    Ding Y; Gong Y; Zeng H; Zhou X; Yu Z; Pan J; Zhou M; Liu S; Lai W
    Aging (Albany NY); 2023 Apr; 15(7):2631-2666. PubMed ID: 37059586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
    Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
    Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCDC134 as a Prognostic-Related Biomarker in Breast Cancer Correlating With Immune Infiltrates.
    Huang Z; Yang L; Chen J; Li S; Huang J; Chen Y; Liu J; Wang H; Yu H
    Front Oncol; 2022; 12():858487. PubMed ID: 35311121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer.
    Shen Y; Xue J; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
    World J Surg Oncol; 2022 Dec; 20(1):398. PubMed ID: 36517818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer.
    Liu S; Ye Z; Xue VW; Sun Q; Li H; Lu D
    BMC Cancer; 2023 Apr; 23(1):307. PubMed ID: 37016301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GNPNAT1 is a potential biomarker correlated with immune infiltration and immunotherapy outcome in breast cancer.
    Yuan R; Zhang Y; Wang Y; Chen H; Zhang R; Hu Z; Chai C; Chen T
    Front Immunol; 2023; 14():1152678. PubMed ID: 37215111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCD3 is a prognostic biomarker for glioma and associated with immune infiltration: A study based on oncolysis of gliomas.
    Li J; Zhang Y; Qu Z; Ding R; Yin X
    Front Cell Infect Microbiol; 2022; 12():956801. PubMed ID: 35959373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pan-cancer analysis to determine the prognostic analysis and immune infiltration of HSPA5.
    Zhu RK; Zhang W; Zhang YX; Hui Z; Wang XW
    Curr Cancer Drug Targets; 2023 May; ():. PubMed ID: 37157205
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
    Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer.
    Song C; Shang F; Tu W; Liu X
    BMC Cancer; 2023 Mar; 23(1):296. PubMed ID: 37004015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors.
    Li Y; Fu W; Geng Z; Song Y; Yang X; He T; Wu J; Wang B
    PeerJ; 2022; 10():e14432. PubMed ID: 36518297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer.
    Li F; Zhang Y; Shi Y; Liu S
    Crit Rev Eukaryot Gene Expr; 2021; 31(4):71-79. PubMed ID: 34587437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
    Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
    Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High FLT3 expression indicates favorable prognosis and correlates with clinicopathological parameters and immune infiltration in breast cancer.
    Chen R; Wang X; Fu J; Liang M; Xia T
    Front Genet; 2022; 13():956869. PubMed ID: 36159964
    [No Abstract]   [Full Text] [Related]  

  • 17. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer.
    Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y
    Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer-testis antigen KK-LC-1 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma.
    Kang Y; Gan Y; Jiang Y; You J; Huang C; Chen Q; Xu X; Chen F; Chen L
    BMC Cancer; 2022 Jul; 22(1):834. PubMed ID: 35907786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of the prognostic value and immune infiltration of
    Yang C; Song D; Zhao F; Wu J; Zhang B; Ren H; Sun Q; Qin S
    Front Oncol; 2022; 12():936952. PubMed ID: 36147913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCDHA1 High Expression is Associated With Poor Prognosis and Correlated With Immune Cell Infiltration in Breast Cancer.
    Du J; Wu K
    Clin Breast Cancer; 2023 Jun; 23(4):397-407. PubMed ID: 36858841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.